• Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
  • Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
  • Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
  • Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
  • Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2

Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Solid
Purity: 95%
Samples:
US$ 150/box 1 box(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
top quality
CAS No.
910463-68-2
Mf
C187h291n45o59
Appearance
Frozen Powder in Vials
Grade Standard
Medicine Grade
MOQ
1 Box
COA
Pls Contact Senwayer Freely
Storge
2-8 Degree
Exp.
10 Months
Transport Package
5mg/Vial
Specification
boxes
Trademark
senwayer
Origin
China
HS Code
2601111000
Production Capacity
800 Boxes Per Week

Product Description

Weight Loss Peptide Semaglutide Injection frozen Powder in vials CAS: 204656-20-2
 

Supply both raw powder and frozen powder vials.

Raw powder is sold per grams.

Frozen powder is sold per box, 5mg/vial, 10 vials/box. can also custom other dose you need.
 


Product Introduction

Product name:Semaglutide
Cas No.:910463-68-2
Molecular formular: C187H291N45O59
Molecular weight : 4113.58
Purity: 98%
Appearance:White Crystalline Powder

 

Semaglutide (USAN; trade name Ozempic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Ozempic. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production of in su lin.It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.


Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment of obesity. It reduces hunger, food craving and body fat.

 

Function 

For research use.
 
Product Name Semaglutide
Cas No. 782487-28-9
Sequence H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Molecular Formula C187H291N45O59
Molar Mass 4,113.64 g·mol
Purity ≥98%
Impurity ≤0.5%
Storage Temperature 2-8ºC
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.

Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2

Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2
Weight Loss Peptide Semaglutide Injection Frozen Powder in Vials CAS: 204656-20-2

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now